Health
Merck ends COVID vaccine program, cites inferior immune responses – Reuters
Drugmaker Merck & Co said on Monday it would stop development of its two COVID-19 vaccines and focus pandemic research on treatments, with initial data on an experimental…
(Reuters) – Drugmaker Merck & Co said on Monday it would stop development of its two COVID-19 vaccines and focus pandemic research on treatments, with initial data on an experimental oral antiviral expected by the end of March.
FILE PHOTO: A scientist is seen in the Themis Bioscience laboratory in Vienna, Austria, in this undated handout photo. Themis Bioscience/Martin Wacht/Handout via REUTERS /File Photo
Merck was late to join the race to develop a vaccine to protect against the coronavirus, which…
-
General15 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business15 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General16 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General18 hours agoAlbanese beats drum on economy as trade clouds gather